Baker Bros. Advisors’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-2,848,567
| Closed | -$132M | – | 111 |
|
|
2019
Q2 | $132M | Sell |
2,848,567
-993,722
| -26% | -$27.9M | 0.9% | 12 |
|
|
2019
Q1 | $93.7M | Sell |
3,842,289
-1,199,407
| -24% | -$25M | 0.6% | 17 |
|
|
2018
Q4 | $71.8M | Sell |
5,041,696
-614,500
| -11% | -$9.32M | 0.59% | 17 |
|
|
2018
Q3 | $86M | Hold |
5,656,196
| – | – | 0.57% | 17 |
|
|
2018
Q2 | $94.9M | Hold |
5,656,196
| – | – | 0.71% | 15 |
|
|
2018
Q1 | $92.3M | Hold |
5,656,196
| – | – | 0.78% | 15 |
|
|
2017
Q4 | $72.4M | Buy |
5,656,196
+442,668
| +8% | +$5.04M | 0.63% | 16 |
|
|
2017
Q3 | $64.1M | Buy |
5,213,528
+3,627,615
| +229% | +$33.7M | 0.52% | 17 |
|
|
2017
Q2 | $13.3M | Hold |
1,585,913
| – | – | 0.12% | 43 |
|
|
2017
Q1 | $14.2M | Sell |
1,585,913
-1,000,000
| -39% | -$10.6M | 0.12% | 40 |
|
|
2016
Q4 | $22.7M | Sell |
2,585,913
-724,753
| -22% | -$5.33M | 0.22% | 32 |
|
|
2016
Q3 | $22.3M | Sell |
3,310,666
-1,000,000
| -23% | -$3.87M | 0.2% | 30 |
|
|
2016
Q2 | $15.3M | Hold |
4,310,666
| – | – | 0.16% | 39 |
|
|
2016
Q1 | $12.7M | Hold |
4,310,666
| – | – | 0.13% | 47 |
|
|
2015
Q4 | $18.2M | Hold |
4,310,666
| – | – | 0.15% | 46 |
|
|
2015
Q3 | $19.7M | Sell |
4,310,666
-1,171,839
| -21% | -$6.95M | 0.18% | 44 |
|
|
2015
Q2 | $39.5M | Sell |
5,482,505
-176,250
| -3% | -$1.3M | 0.35% | 31 |
|
|
2015
Q1 | $41.7M | Buy |
5,658,755
+4,224,958
| +295% | +$30.1M | 0.35% | 27 |
|
|
2014
Q4 | $6.78M | Hold |
1,433,797
| – | – | 0.07% | 64 |
|
|
2014
Q3 | $5.12M | Hold |
1,433,797
| – | – | 0.06% | 61 |
|
|
2014
Q2 | $6.54M | Hold |
1,433,797
| – | – | 0.08% | 59 |
|
|
2014
Q1 | $6.74M | Sell |
1,433,797
-66,203
| -4% | -$333K | 0.09% | 62 |
|
|
2013
Q4 | $7.51M | Hold |
1,500,000
| – | – | 0.11% | 53 |
|
|
2013
Q3 | $9.33M | Hold |
1,500,000
| – | – | 0.13% | 44 |
|
|
2013
Q2 | $6.81M | Buy |
+1,500,000
| New | +$8.07M | 0.13% | 42 |
|
Other funds holding ARRY
Baker Bros. Advisors's ARRY Position: Q3 2019 in Review
Baker Bros. Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 2,848,567 shares — an estimated $132M sold.
Baker Bros. Advisors first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $132M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Baker Bros. Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Baker Bros. Advisors sold 2,848,567 Array Biopharma Inc shares in Q3 2019, an estimated $132M.
- Baker Bros. Advisors first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
- Baker Bros. Advisors's Array Biopharma Inc position peaked at $132M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Baker Bros. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.